Like a great orchestra, your brain relies on the perfect coordination of many elements to function properly. And if one of those elements is out of sync, it affects the entire ensemble. In Alzheimer’s disease, for instance, damage to specific neurons can alter brainwave rhythms and cause a loss of cognitive functions.
One type of neuron, called inhibitory interneuron, is particularly important for managing brain rhythms. It’s also the research focus of a laboratory led by Jorge Palop, PhD, assistant investigator at the Gladstone Institutes. In a study published in Neuron, Palop and his collaborators uncovered the therapeutic benefits of genetically improving these interneurons and transplanting them into the brain of a mouse model of Alzheimer’s disease.
Interneurons control complex networks between neurons, allowing them to send signals to one another in a harmonized way. You can think of inhibitory interneurons as orchestra conductors. They create rhythms in the brain to instruct the players—excitatory neurons—when to play and when to stop. An imbalance between these two types of neurons creates disharmony and is seen in multiple neurological and psychiatric disorders, including Alzheimer’s disease, epilepsy, schizophrenia, and autism.
A Brain without a Conductor
Palop’s previous studies showed that, in mouse models of Alzheimer’s, the inhibitory interneurons do not work properly. So, the rhythms that organize the excitatory cells are disturbed and fail to function harmoniously, causing an imbalance in brain networks. This, in turn, affects memory formation and can lead to epileptic activity, which is often observed in patients with Alzheimer’s disease.
His team found a way to reengineer inhibitory interneurons to improve their function. They showed that these enhanced interneurons, when transplanted into the abnormal brain of Alzheimer mice, can properly control the activity of excitatory cells and restore brain rhythms.
“We took advantage of the fact that transplanted interneurons can integrate remarkably well into new brain tissues, and that each interneuron can control thousands of excitatory neurons,” said Palop, who is also an assistant professor of neurology at the University of California, San Francisco. “These properties make interneurons a promising therapeutic target for cognitive disorders associated with brain rhythm abnormalities and epileptic activity.”
First, the scientists had to overcome a significant challenge. When they transplanted regular interneurons, they saw no beneficial effects, presumably because Alzheimer’s disease creates a toxic environment in the brain.
The researchers then genetically boosted the activity of inhibitory interneurons by adding a protein called Nav1.1. They discovered that the interneurons with enhanced function were able to overcome the toxic disease environment and restore brain function.
“These optimized neurons are like master conductors,” said Palop. “Even with a declining orchestra, they can restore the rhythms and harmony needed for cognitive functions.”
Conductors Engineered for Alzheimer’s Disease
The findings could eventually lead to the development of new treatment options for patients with Alzheimer’s disease.
“Besides the applications this cell engineering and transplantation approach may find in regenerative medicine, our findings support the broader concept that enhancing the function of interneurons can counteract key aspects of Alzheimer’s disease,” said Lennart Mucke, MD, director of the Gladstone Institute of Neurological Disease.
In addition to examining if the cell therapy could be translated from mice to humans, Palop and his team are working to identify potential drugs as an alternative way to enhance the function of inhibitory interneurons.
The Latest on: Alzheimer’s Disease
via Google News
The Latest on: Alzheimer’s Disease
- U Chicago professor leads study on importance of smell for Alzheimer’s disease, dementiaon August 1, 2022 at 12:36 pm
A person’s loss of smell could predict changes in regions of the brain important to detect Alzheimer’s disease and dementia, according to a study by researchers at the University of Chicago.
- ALZ-NET: First data collection and sharing network for new FDA-approved Alzheimer's treatmentson August 1, 2022 at 10:40 am
ALZ-NET is the first network developed specifically for new FDA-approved Alzheimer's treatments, collecting real-world evidence on drug effectiveness and side effects over a long period of time.
- Alzheimer’s Researchers Are Looking Beyond Plaques And Tangles For New Treatmentson August 1, 2022 at 10:26 am
An atlas showing how Alzheimer's changes individual brain cells could help researchers find new treatments for the disease.
- To Beat Alzheimer’s, Scientists Try New Ideas, Including Brain Mappingon August 1, 2022 at 9:50 am
Media outlets report on research into Alzheimer’s disease, including expanding fields of study and the potential for a diabetes drug to help protect against the illness. USA Today and The ...
- The Woman's Doctor: Alzheimer's Disease is twice as common in womenon August 1, 2022 at 6:50 am
In this Woman's Doctor segment, we discuss Alzheimer's Disease. It is twice as common in women compared to men.
- Strawberries Reduce Risk for Alzheimer's Diseaseon August 1, 2022 at 6:49 am
Strawberries may reduce the risk for Alzheimer’s disease, according to results published in the Journal of Alzheimer’s Disease.
- Cognito Therapeutics Announces Proprietary Gamma Sensory Stimulation for 6-Months Reduces White Matter Atrophy in Alzheimer’s Disease Patientson August 1, 2022 at 5:00 am
Pivotal trials will launch this year to support clinical efficacy of gamma sensory stimulation in Alzheimer’s Disease. Cognito Therapeutics, announced today that its proprietary gamma sensory ...
- This doctor reversed heart disease. Now he wants to do it for Alzheimer'son July 31, 2022 at 3:33 pm
Using a strict vegan diet, exercise, stress reduction and social support, Dr. Dean Ornish reversed heart disease in a 1990 clinical trial. Today he's trying to use the same approach on dementia.
- Cell by cell, scientists are building a high-resolution map of brain changes in Alzheimer's diseaseon July 28, 2022 at 12:22 am
If you compare the brain of someone who has died from neurodegenerative disease to that of a healthy person, you can't miss the difference: In the case of severe Alzheimer's, the brain will be ...
via Bing News